Literature DB >> 15836960

Multiple sites of tumorigenesis in transgenic mice overproducing hCG.

Ilpo Huhtaniemi1, Susana Rulli, Petteri Ahtiainen, Matti Poutanen.   

Abstract

We have produced transgenic (TG) mice expressing under the ubiquitin C promoter either the glycoprotein hormone common alpha-subunit (C(alpha)) or human chorionic gonadotropin (hCG) beta-subunit. C(alpha) overexpression alone had no phenotypic effect, but the hCG(beta) expressing females, presenting with moderately elevated levels of bioactive LH/hCG, due to dimerization of the TG hCG(beta) with endogenous C(alpha), developed multiple gonadal and extragonadal neoplasias. Crosses of the C(alpha) and hCG(beta) mice (hCG(alpha)beta) had >1000-fold elevated hCG levels, due to ubiquitous transgene expression, and presented with more aggressive tumour formation. The ovaries displayed initially strong luteinisation of all somatic cell types, leading to formation of luteomas, and subsequently to germ cell tumours (teratomas). The pituitary glands of TG females were massively enlarged, up to >100 mg, developing macroprolactinomas with very high prolactin (PRL) production. This endocrine response probably induced breast cancers in the mice. In contrast to the females, similar high levels of hCG in male mice had only marginal effects in adulthood, with slight Leydig cell hyperplasia and atrophy in the seminiferous epithelium. However, clear Leydig cell adenomas were observed in postnatal mice, apparently originating from fetal Leydig cells. In conclusion, these studies demonstrate marked tumorigenic effects of supraphysiological hCG levels in female mice, but clear resistance to similar changes in males. The extragonadal tumours were induced by hCG stimulated aberrant ovarian endocrine function, rather than by direct hCG action, because gonadectomy prevented all extragonadal phenotypes despite persistent hCG elevation. The phenotypes of the TG mice apparently represent exaggerated responses to hCG/LH and/or gonadal steroids. It remains to be explored to what extent they simulate respective responses in humans to pathophysiological elevation of the same hormones.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15836960     DOI: 10.1016/j.mce.2004.10.013

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  15 in total

1.  Female mice expressing constitutively active mutants of FSH receptor present with a phenotype of premature follicle depletion and estrogen excess.

Authors:  Hellevi Peltoketo; Leena Strauss; Riikka Karjalainen; Meilin Zhang; Gordon W Stamp; Deborah L Segaloff; Matti Poutanen; Ilpo T Huhtaniemi
Journal:  Endocrinology       Date:  2010-02-19       Impact factor: 4.736

Review 2.  The mammalian ovary from genesis to revelation.

Authors:  Mark A Edson; Ankur K Nagaraja; Martin M Matzuk
Journal:  Endocr Rev       Date:  2009-09-23       Impact factor: 19.871

3.  Infertility in Female Mice with a Gain-of-Function Mutation in the Luteinizing Hormone Receptor Is Due to Irregular Estrous Cyclicity, Anovulation, Hormonal Alterations, and Polycystic Ovaries.

Authors:  Lan Hai; Stacey R McGee; Amanda C Rabideau; Marilène Paquet; Prema Narayan
Journal:  Biol Reprod       Date:  2015-06-03       Impact factor: 4.285

4.  Luteinizing hormone receptor deficiency increases the susceptibility to alkylating agent-induced lymphomagenesis in mice.

Authors:  Yinghao Yu; Fangping Yuan; Xian Li; Dexin Lin; Zijian Lan; C V Rao; Zhenmin Lei
Journal:  Horm Cancer       Date:  2010-10       Impact factor: 3.869

5.  Activation of the lutropin/choriogonadotropin receptor in MA-10 cells stimulates tyrosine kinase cascades that activate ras and the extracellular signal regulated kinases (ERK1/2).

Authors:  Koji Shiraishi; Mario Ascoli
Journal:  Endocrinology       Date:  2006-04-13       Impact factor: 4.736

6.  The ERK1/2 pathway regulates testosterone synthesis by coordinately regulating the expression of steroidogenic genes in Leydig cells.

Authors:  Maria Eugenia Matzkin; Soichi Yamashita; Mario Ascoli
Journal:  Mol Cell Endocrinol       Date:  2013-03-07       Impact factor: 4.102

7.  Luteinizing hormone promotes gonadal tumorigenesis in inhibin-deficient mice.

Authors:  Ankur K Nagaraja; Julio E Agno; T Rajendra Kumar; Martin M Matzuk
Journal:  Mol Cell Endocrinol       Date:  2008-07-09       Impact factor: 4.102

8.  TGF-β-induced hCG-β regulates redox homeostasis in glioma cells.

Authors:  Fahim Ahmad; Sadashib Ghosh; Sanchari Sinha; Shanker Datt Joshi; Veer Singh Mehta; Ellora Sen
Journal:  Mol Cell Biochem       Date:  2014-10-10       Impact factor: 3.396

9.  Lutropin/choriogonadotropin stimulate the proliferation of primary cultures of rat Leydig cells through a pathway that involves activation of the extracellularly regulated kinase 1/2 cascade.

Authors:  Koji Shiraishi; Mario Ascoli
Journal:  Endocrinology       Date:  2007-04-05       Impact factor: 4.736

10.  Transgenesis-mediated reproductive dysfunction and tumorigenesis: effects of immunological neutralization.

Authors:  Ruchi Sachdeva; Neetu Bhardwaj; Ilpo Huhtaniemi; Usha Aggrawal; Swatantra Kumar Jain; Rana Zaidi; Om Singh; Rahul Pal
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.